Great Boulder (ASX: GBR) Confirms Nickel-copper-cobalt sulphide mineralization As Stock Takes A Breather

Great Boulder Confirms Nickel-copper

Great Boulder shares rallied around 40% this month as the news of the company hitting a major sulphide mineralization at the Eastern Mafic Complex broke.

The company recently announced about their first assays from drilling work being conducted at the Easter Mafic complex. Located at the 130 km east from Laverton in WA, the site exhibit rich presence of nickel-copper-cobalt sulphide mineralization. The examination from the first two holes at the Zermatt hints towards the significant improvement in the nickel grade and tenor.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

What Mt Venn holds for GBR

Great boulder believes that Mt Venn and Eastern Mafic complex are the rich source of copper-Nickel-cobalt magmatic system. During the gravity survey, Eastern Mafic indicated an underlying large stock of copper, cobalt sulphide mineralization and nickel. It is believed that the area around AEM conductor 22 has close to 100m below surface which could be extending to around 400m in strike. This finding translates into large chunk of Sulphide present in the area. The findings and progress matters because the company is exploring into the live system that can promise huge scale and apt geological benefit.

The late – time electromagnetic response suggested the presence of bedrock source. Investors took the share price since the theory is in line with the practical aspect. Add the grade to the massive size of the area, GBR might be on its way to have its hands on something significant. At its northern extension, there have been wide intervals of mineralization witnessed stretching to the strike length of 300 meters across the directions. The company is hopeful to complete the drilling at Mt Venn in next couple of weeks before restarting the work at the Eastern Mafic.

The stock price has gapped down today but held on to its crucial support level of $ 0.268. However, there was no exceptional spurt witnessed in the volume during the fall, suggesting the price movement might just be a profit taking event by the investors.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report